Gold Nanocluster-Based Fluorescence Turn-off Probe for Sensing of Doxorubicin by Photoinduced Electron Transfer

Kai-Yuan Huang,Hong-Xing He,Shao-Bin He,Xiang-Ping Zhang,Hua-Ping Peng,Zhen Lin,Hao-Hua Deng,Xing-Hua Xia,Wei Chen
DOI: https://doi.org/10.1016/j.snb.2019.126656
2019-01-01
Abstract:Doxorubicin (DOX), an anthraquinone-based anticancer drug, is effective for the treatment of a variety of human tumors. However, due to its narrow therapeutic window, serum levels need to be closely monitored. Herein, we report the development of a novel fluorescence probe based on gold nanoclusters co-modified with dithiothreitol (DTT) and carboxylated chitosan (CC) (CC/DTT-AuNCs) for the determination of DOX. The emission from the CC/DTT-AuNCs is significantly suppressed by DOX. The fluorescence-quenching mechanism involving DOX was systematically explored, and photoinduced electron transfer was identified to play a dominant role. DOX readily binds to the CC/DTT-AuNC surface through electrostatic attraction, after which it accepts the electron from the photoexcited CC/DTT-AuNC and quenches its fluorescence. We found that other anthraquinone structures (e.g., alizarin and emodin) devoid of -NH2 groups exhibited almost no CC/DTT-AuNCs fluorescence-quenching effect due to weak electrostatic interactions between these anthraquinones and the NCs. A linear relationship between photoluminescence suppression and the concentration of DOX was observed in the 0.05-2 mu M range under the optimal experimental conditions, with a detection limit as low as 5 nM. This new sensing approach was also used to successfully measure DOX in human serum samples with satisfactory results obtained.
What problem does this paper attempt to address?